Assessing antiangiogenic therapy response by DCE-MRI: development of a physiology driven multi-compartment model using population pharmacometrics.
Dynamic contrast enhanced (DCE-) MRI is commonly applied for the monitoring of antiangiogenic therapy in oncology. Established pharmacokinetic (PK) analysis methods of DCE-MRI data do not sufficiently reflect the complex anatomical and physiological constituents of the analyzed tissue. Hence, accept...
Main Authors: | Andreas Steingoetter, Dieter Menne, Rickmer F Braren |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3196562?pdf=render |
Similar Items
-
Theoretical Compartment Modeling of DCE-MRI Data Based on the Transport across Physiological Barriers in the Brain
by: Laura Fanea, et al.
Published: (2012-01-01) -
Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI.
by: Wenlian Zhu, et al.
Published: (2014-01-01) -
Tracer-kinetic model-driven motion correction with application to renal DCE-MRI
by: Flouri, Dimitra
Published: (2016) -
Analysis of Necrosis for Osteosarcoma DCE-MRI
by: Yong-Long Huang, et al.
Published: (2010) -
Pharmacometrics and/or Systems Pharmacology
by: Piet H. van derGraaf
Published: (2019-06-01)